Abstract:This paper examines the role of provider payment policy as an instrument for addressing government and market failures and controlling costs in the health sector, particularly in developing countries. We empirically evaluate the impact of provider payment reform in Hainan province, China, on expenditures for different categories of services that had been subject to distorted prices under fee-for-service. Using a pre-post study design with a control group, we analyze two years of claims data to assess the impact of a January 1997 change to prospective payment for a sub-sample of the hospitals. This difference-in-difference empirical strategy allows us to isolate the supply-side payment reform effects from demand-side policy interventions. We find that prepayment is associated with a slower increase in spending on expensive drugs and high technology services, compared to fee-for-service. The fact that payment reform is associated with reduced growth in spending on the most expensive drugs is particularly encouraging, given that drugs account for a remarkably high percentage of both the level and growth of aggregate health expenditure in China. Payment reform can be an effective policy instrument for correcting market failures and adverse side effects of government health sector interventions (such as distorted prices to assure access to basic services), both of which can lead to excessive health care expenditure growth. Such health spending growth can have a particularly high opportunity cost for developing countries.

Hospitals and drug manufacturing and distribution industries acclimate the compensation policy: stirring overly expensive medical services

Causes of the unduly rapid growth of drug expenses in China and countermeasures

Price Controls of Health Service and the System of Underpaid Doctors Compensated by the Excessive Medical Expense

The Semi Centennial Policies of Price Cutting and Fixing Lead to the Abnormality of the Charge Standard of Medical Services

Analysis and Suggestion on the Compensation Mechanism of Public Hospitals after Abolishing Drug Price Addition

Rome is Not Built in a Day: the Problem of Overly Expensive Medical Services is the Result of Social Interaction

Does Hospital Income Structure Adjustment Can Alleviate the Expensive Health Care?

The exploration on government compensation methods for public hospitals: The way on the basis of service volume

The Technologies to Solve the Problems Such As Overly Expensive Medical Services Are Very Mature, but the Key is the Decision of the Government

A Study on the Current Mechanism of Pricing and Compensation in Medical Service

Hospital becomes profit oriented "economic entity" with the macro-policy reformed and the fiscal obligation changed

Study on Compensation Mechanism of Public Hospitals under New Medical Reform

The economic effect of financial compensation in China's healthcare system: comprehensive insights regarding supply and demand factors

How does the pharmaceutical industry influence prescription? A qualitative study of provider payment incentives and drug remunerations in hospitals in Shanghai

An Empirical Study on the Impact of the Compensation Mechanism Reform on Public Hospitals'Social Role Behaviors

Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China

Report on the compensation mechanism of primary medical and health institutions in China

Health in China. the Healthcare Market.

Reform of physicians'compensation system of public hospitals in China

A Brief Discussion on the Compensation Mechanism of Professional Stations for Disease Control and Prevention in China

The Price Control Issues in Health Care(Part Three) :The Price Control on Physician's Labor